Serum asprosin levels are associated with obesity and insulin resistance in Arab adults

Background: Asprosin, a novel adipokine, has been implicated in glucose regulation, insulin production, and appetite stimulation. Hence, the current study explores circulating asprosin levels and their associations with insulin resistance (IR) and other parameters in obese and type 2 diabetes mellit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nasser M. Al-Daghri, Reem M.I. Alokeel, Abir Alamro, Mohammed G.A. Ansari, Syed D. Hussain, Osama E. Amer, Sobhy M. Yakout, Abdullah M. Alnaami, Shaun Sabico
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/d93e1554f7924b519277d05f2e9ea057
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d93e1554f7924b519277d05f2e9ea057
record_format dspace
spelling oai:doaj.org-article:d93e1554f7924b519277d05f2e9ea0572021-11-20T04:56:05ZSerum asprosin levels are associated with obesity and insulin resistance in Arab adults1018-364710.1016/j.jksus.2021.101690https://doaj.org/article/d93e1554f7924b519277d05f2e9ea0572022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1018364721003529https://doaj.org/toc/1018-3647Background: Asprosin, a novel adipokine, has been implicated in glucose regulation, insulin production, and appetite stimulation. Hence, the current study explores circulating asprosin levels and their associations with insulin resistance (IR) and other parameters in obese and type 2 diabetes mellitus (T2DM) Saudi subjects. Methods: A total of N = 291 (89 control, 105 T2DM/obese and 97 obese) subjects were included in this cross-sectional study. Fasting glucose and lipid profiles were measured routinely. Adiponectin, leptin, C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, IL-1, and asprosin were measured using commercially available assays. Results: Serum asprosin levels were found to be significantly highest in obese subjects [3.7 ng/ml (2.6–5.0)] than T2DM/obese [0.1 ng/ml (0.0–0.4)] and controls [0.2 ng/ml (0.1–0.3)] (p < 0.001). In the T2DM/obese group, users of metformin alone or in combination had significantly lower asprosin levels than those whose medication history was unknown [0.03 ng/ml (0.02–0.05) versus 0.2 ng/ml (0.1–0.4); p < 0.001]. Stepwise multiple linear regression analysis revealed that only glucose, insulin and adiponectin were the most important predictors of asprosin, explaining 61.3% (p < 0.001) of the variances perceived. Conclusion: Asprosin levels are associated with markers of IR independent of adiposity and inflammation and are influenced by oral hypoglycemics, particularly metformin.Nasser M. Al-DaghriReem M.I. AlokeelAbir AlamroMohammed G.A. AnsariSyed D. HussainOsama E. AmerSobhy M. YakoutAbdullah M. AlnaamiShaun SabicoElsevierarticleAsprosinObesityInsulin resistanceBiomarkerSaudiScience (General)Q1-390ENJournal of King Saud University: Science, Vol 34, Iss 1, Pp 101690- (2022)
institution DOAJ
collection DOAJ
language EN
topic Asprosin
Obesity
Insulin resistance
Biomarker
Saudi
Science (General)
Q1-390
spellingShingle Asprosin
Obesity
Insulin resistance
Biomarker
Saudi
Science (General)
Q1-390
Nasser M. Al-Daghri
Reem M.I. Alokeel
Abir Alamro
Mohammed G.A. Ansari
Syed D. Hussain
Osama E. Amer
Sobhy M. Yakout
Abdullah M. Alnaami
Shaun Sabico
Serum asprosin levels are associated with obesity and insulin resistance in Arab adults
description Background: Asprosin, a novel adipokine, has been implicated in glucose regulation, insulin production, and appetite stimulation. Hence, the current study explores circulating asprosin levels and their associations with insulin resistance (IR) and other parameters in obese and type 2 diabetes mellitus (T2DM) Saudi subjects. Methods: A total of N = 291 (89 control, 105 T2DM/obese and 97 obese) subjects were included in this cross-sectional study. Fasting glucose and lipid profiles were measured routinely. Adiponectin, leptin, C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, IL-1, and asprosin were measured using commercially available assays. Results: Serum asprosin levels were found to be significantly highest in obese subjects [3.7 ng/ml (2.6–5.0)] than T2DM/obese [0.1 ng/ml (0.0–0.4)] and controls [0.2 ng/ml (0.1–0.3)] (p < 0.001). In the T2DM/obese group, users of metformin alone or in combination had significantly lower asprosin levels than those whose medication history was unknown [0.03 ng/ml (0.02–0.05) versus 0.2 ng/ml (0.1–0.4); p < 0.001]. Stepwise multiple linear regression analysis revealed that only glucose, insulin and adiponectin were the most important predictors of asprosin, explaining 61.3% (p < 0.001) of the variances perceived. Conclusion: Asprosin levels are associated with markers of IR independent of adiposity and inflammation and are influenced by oral hypoglycemics, particularly metformin.
format article
author Nasser M. Al-Daghri
Reem M.I. Alokeel
Abir Alamro
Mohammed G.A. Ansari
Syed D. Hussain
Osama E. Amer
Sobhy M. Yakout
Abdullah M. Alnaami
Shaun Sabico
author_facet Nasser M. Al-Daghri
Reem M.I. Alokeel
Abir Alamro
Mohammed G.A. Ansari
Syed D. Hussain
Osama E. Amer
Sobhy M. Yakout
Abdullah M. Alnaami
Shaun Sabico
author_sort Nasser M. Al-Daghri
title Serum asprosin levels are associated with obesity and insulin resistance in Arab adults
title_short Serum asprosin levels are associated with obesity and insulin resistance in Arab adults
title_full Serum asprosin levels are associated with obesity and insulin resistance in Arab adults
title_fullStr Serum asprosin levels are associated with obesity and insulin resistance in Arab adults
title_full_unstemmed Serum asprosin levels are associated with obesity and insulin resistance in Arab adults
title_sort serum asprosin levels are associated with obesity and insulin resistance in arab adults
publisher Elsevier
publishDate 2022
url https://doaj.org/article/d93e1554f7924b519277d05f2e9ea057
work_keys_str_mv AT nassermaldaghri serumasprosinlevelsareassociatedwithobesityandinsulinresistanceinarabadults
AT reemmialokeel serumasprosinlevelsareassociatedwithobesityandinsulinresistanceinarabadults
AT abiralamro serumasprosinlevelsareassociatedwithobesityandinsulinresistanceinarabadults
AT mohammedgaansari serumasprosinlevelsareassociatedwithobesityandinsulinresistanceinarabadults
AT syeddhussain serumasprosinlevelsareassociatedwithobesityandinsulinresistanceinarabadults
AT osamaeamer serumasprosinlevelsareassociatedwithobesityandinsulinresistanceinarabadults
AT sobhymyakout serumasprosinlevelsareassociatedwithobesityandinsulinresistanceinarabadults
AT abdullahmalnaami serumasprosinlevelsareassociatedwithobesityandinsulinresistanceinarabadults
AT shaunsabico serumasprosinlevelsareassociatedwithobesityandinsulinresistanceinarabadults
_version_ 1718419744571260928